1 Department of Oral Implantology, Jacksonville University, Jacksonville, USA. 2 Department of Mechanical Engineering, University of Connecticut, Storrs, USA. After cleaning and shaping during ...

Adenocarcinoma is the most common type of prostate cancer and affects over 95% of cases. Small-cell carcinoma is an aggressive type of prostate cancer that often spreads quickly. Transitional cell ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

DEAR DR. ROACH: I have been treated for prostate cancer and stopped my semiannual Eligard injections three years ago. I’m 75 years old and about 5 feet, 9 inches tall. Before treatment, I weighed 227 ...

After a prostate cancer diagnosis, the way your doctor describes your cancer can help you understand what to expect next. “Low-risk cancers often use active surveillance. Intermediate-risk cancers ...

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc.

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...

July 23, 2025—AngioDynamics, Inc. announced the publication of results from the PRESERVE study, which assessed the safety and effectiveness of irreversible electroporation (IRE) with the company’s ...